HIV Global Forum: Integrase Inhibitors 2018

 

Saturday- 21 July 2018

 Session 1  -  Update on Clinical Management using Integrase Inhibitors
 State of the ART: Integrase Inhibitors Resistance
(Not yet available)

Jeroen van Kampen, MD, PhD
Erasmus Medical Center, Rotterdam, The Netherlands
 State of the ART: Integrase Inhibitors (clinical overview)
Mauro Schechter, MD, PhD
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
 

Clinical case presentation 
(Not available)
Charles Boucher, MD, PhD 
Erasmus Medical Center, Rotterdam, The Netherlands

 

van Kampen, Jeroen 2018_120

Jeroen van Kampen, MD, PhD
Erasmus Medical Center, Rotterdam, The Netherlands

  
 Session 2  -  Changing the paradigm: Is reducing drug regimen an option?
 What is the Clinical support for reduce drug regimens?
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, London, United Kingdom
 What is the Virological support for reduced drug regimens?
Daniel Kuritzkes, MD
Harvard Medical School, Cambridge, USA
 What is the Pharmacological support for reduce drug regimens?
David Back, PhD
University of Liverpool, Liverpool, United Kingdom
  
 Session 3  -  Use of Integrase Inhibitors in special patient populations
 Expanding Integrase Inhibitors in the rest of Europe
Milosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
 Integrase Inhibitors in children
(Not yet available) 

Natella Rakhmanina, MD, PhD, FAAP, AAHIV
Children's National Medical Center, Washington DC, USA
 Implication of the resent Dolutegravir data 
Rebecca Zash, MD
Beth Israel Deaconess Medical Center, Boston (MA), USA
 Clinical case: Integrase Inhibitors in Africa 
Julia Turner, MD
Right to Care, Johannesburg, South Africa
  
 Session 4  -  Novel treatment strategies / delivery systems
 Designing e-health interventions for HIV care
Guido van den Berk, MD
Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
 One pill a day?: Integration novel delivery systems into routine care
Terry Blaschke, MD
Bill & Melinda Gates Foundation, Stanford, CA, USA